These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2738671)

  • 21. [Mobile table for salpingography].
    SLANINA J
    Cesk Rentgenol; 1957 Aug; 11(3):210-2. PubMed ID: 13472860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Salpingochemography and ovulation].
    NOCETI JE
    Sem Med; 1954 May; 104(20):633-6; passim. PubMed ID: 13178748
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium 99m-labeled microspheres and macroaggregates.
    Makrigiorgos GM; Adelstein SJ; Kassis AI
    JAMA; 1990 Aug; 264(5):592-5. PubMed ID: 2366298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetry of swallowed non-absorbed technetium 99m radiopharmaceuticals in paediatric patients.
    Stabin MG; Stubbs JB; Watson EE
    Eur J Nucl Med; 1991; 18(4):288-92. PubMed ID: 2070807
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of technetium 99m as a clinical tracer element.
    Herbert R; Kulke W; Shepherd RT
    Postgrad Med J; 1965 Nov; 41(481):656-62. PubMed ID: 5840856
    [No Abstract]   [Full Text] [Related]  

  • 26. Radionuclide hysterosalpingography for evaluation of fallopian tube patency.
    McCalley MG; Braunstein P; Stone S; Henderson P; Egbert R
    J Nucl Med; 1985 Aug; 26(8):868-74. PubMed ID: 4032035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [About the possibility of fallopian tubes patency evaluations by means of 99mTc-pertechnetate and comparison of radiation loads due to radioisotopic and x-ray examinations (author's transl)].
    Rýznar V; Heczko P; Husák V; Gazárek F; Wiedermann M; Erban J; Pohanka J
    Cesk Gynekol; 1981 Nov; 46(9):692-5. PubMed ID: 6272998
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiation exposure of the ovaries during hysterosalpingography. Is radionuclide hysterosalpingography justified?
    van der Weiden RM; van Zijl J
    Br J Obstet Gynaecol; 1989 Apr; 96(4):471-2. PubMed ID: 2751961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indication and clinical application of radionuclide hysterosalpingography using 99mTc-pertechnetate.
    Rýznar V; Heczko P; Husák V; Gazárek F; Pohanka J; Zenísek L; Wiedermann M; Erban J
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():185-93. PubMed ID: 6100765
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiation dosimetry in radionuclide hysterosalpingography with technetium-99m.
    Stabin M
    J Nucl Med; 1989 Mar; 30(3):415-6. PubMed ID: 2738671
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.